Clinical Trial Update: Prevention of CHOP-induced Chronic Cardiotoxicity [Phase 4]

View source ↗

Summary

Phase 4 trial update focusing on preventing chronic cardiotoxicity from CHOP chemotherapy in patients with non-Hodgkin's lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Osaka City University | Conditions: Non-Hodgkin's Lymphoma | Phase 4 | Status: COMPLETED